Experimental hearing loss drug enters next phase of testing
An experimental hearing loss drug that’s delivered directly into the eardrum moved to the next phase of drug testing, reported Massachusetts-based Frequency Therapeutics, the drug’s developer, in late 2019. The experimental drug is delivered viainjection into the middle ear, whereit is absorbed by the inner ear. The drug, dubbed FX-322, is given via injection into the… Read More »